Oncology

Atlanta-based Piedmont Healthcare has tapped Amy Edwards, MSN, as vice president of oncology.  Ms. Edwards previously served as director of care standardization and optimization for Atlanta-based Winship Cancer Institute at Emory Healthcare, according to an Oct. 16 news release from…

There will be an expected 18.6 million deaths from cancer globally in 2050, up from 10.4 million cancer deaths in 2023, according to a study published Sept. 24 in The Lancet.  For their analysis, researchers used the Global Burden of…

“Turmoil at NIH and other federal health agencies threatens ongoing and future progress for patients,” the American Association for Cancer Research said in a Sept. 17 news release announcing its 2025 Cancer Progress Report.  The AACR found a 34% reduction…

From organ preservation to surgical technique, lung transplant medicine has undergone a series of quiet revolutions — and the demands on hospitals are changing with it. Gerard Criner, MD, director of the Temple Lung Center at Philadelphia-based Temple Health, who…

A $3.5 million philanthropic gift is helping Cleveland-based University Hospitals Seidman Cancer Center triple its clinical trial capacity by 2030 — part of a broader push to expand cancer research and innovation while decentralizing early-phase trial access across its 23-hospital…

Robert Winn, MD, had only one thing on his mind when Becker’s asked him what area of oncology deserved more attention: the workforce shortage Dr. Winn is the director and Lipman Chair in Oncology at Richmond, Va.-based VCU Massey Comprehensive…

Tampa, Fla.-based Moffitt Cancer Center has launched a venture studio aimed at leveraging insights from health systems’ intellectual property — starting with Moffitt’s own —  to develop “scalable solutions” for unmet clinical needs. The center’s AccelerOnco Studio is the first…

The overall cancer death rate decreased by 34% between 1991 and 2023, according to the American Association for Cancer Research’s Cancer Progress Report. The report ties the declining death rate, therapeutic innovations and improved screening practices to medical research conducted…

Wilmington, Del.-based Nemours Children’s has appointed Douglas Harrison, MD, as division chief of hematology, oncology, transplant and cellular therapy, as well as the Lisa Dean Moseley Foundation Presidential Endowed Chair. Dr. Harrison will shape the strategy of the Lisa Dean…

The ability to identify patients at increased risk for hereditary cancer has never been more achievable, yet it’s still far from routine. National guidelines and accreditation programs call for proactive risk assessment and genetic testing. Still, many patients who meet…